Shopping Cart
- Remove All
Your shopping cart is currently empty
Theliatinib (Xiliertinib) tartrate is a potent and highly selective EGFR inhibitor with ATP-competitive and orally active properties, showing a K_i of 0.05 nM and an IC_50 of 3 nM for EGFR, and an IC_50 of 22 nM for the EGFR T790M/L858R mutant, with over 50-fold selectivity for EGFR compared to other kinases.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $1,520 | 1-2 weeks | |
| 50 mg | $1,980 | 1-2 weeks | |
| 100 mg | $2,500 | 1-2 weeks |
| Description | Theliatinib (Xiliertinib) tartrate is a potent and highly selective EGFR inhibitor with ATP-competitive and orally active properties, showing a K_i of 0.05 nM and an IC_50 of 3 nM for EGFR, and an IC_50 of 22 nM for the EGFR T790M/L858R mutant, with over 50-fold selectivity for EGFR compared to other kinases. |
| Synonyms | Xiliertinib tartrate ; HMPL-309 tartrate, Xiliertinib tartrate, HMPL-309 tartrate |
| Molecular Weight | 592.6 |
| Formula | C29H32N6O8 |
| Cas No. | 2413487-72-4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.